Honorary Fellowship for Trevor Jones

Published: 1-May-2005
Media


Prof Trevor Jones CBE, until recently director general of the ABPI and formerly r&d director at Wellcome, has been awarded an Honorary Fellowship of the British Pharmacological Society. Prof Jones is a member of the board of Allergan, chairman of the stem cell company ReNeuron and a senior r&d advisor to Esteve. He is also on the board of NextPharma.

Awarded honorary doctorates from five universities, he is a Fellow of Kings College, Fellow of the Royal Society of Chemistry and Fellow of the Royal Pharmaceutical Society of Great Britain. He has also been awarded an honorary Fellowship of the faculty of Pharmaceutical Medicine of the The Royal College of Physicians.

A founder member of the Geneva-based, public:private partnership, Medicines for Malaria Venture (MMV), in 2004 he was appointed to the World Health Organisation (WHO) Commission on Intellectual Property Rights and International Health (CIPIH).

  • Companies:
  • Nextpharma
See more

You may also like

Media

NextPharma sterile product development centre in Belgium receives AFMPS approval

Read more
European contract manufacturer NextPharma has received approval from the AFMPS (Belgian Regulatory Authority) for its new Sterile Product Development Centre (SPDC) in Braine l'Alleud, Belgium.

Trending Articles

  1. Can Aztekin receives Rising Star Award 2025 from the International Society of Regenerative Biology
  2. Royal Society of Chemistry and TIB co-create next generation Open Access consortium model The agreement delivers shared goals of equity for institutions, a community approach and universal open access for authors
  3. BioIVT acquires Optivia Biotechnology The acquisition strengthens BioIVT’s transporter sciences capabilities and will enable it to partner with customers on new drug applications and mechanistic studies related to transporters
  4. The Lab Awards: from balances to the ball The Lab Awards, the leading awards ceremony for the UK’s laboratory industry, was held at The Vox, Birmingham, on 1 November and celebrated the lab industry’s key achievements from the past year
  5. Reaping the benefits of a continuous process Growing interest in continuous processing reflects expectations that technological innovation can benefit operations across the board, says Guy Tiene, That’s Nice Director of Strategic Content

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Media

NextPharma sterile product development centre in Belgium receives AFMPS approval

<p>European contract manufacturer NextPharma has received approval from the AFMPS (Belgian Regulatory Authority) for its new Sterile Product Development Centre (SPDC) in Braine l'Alleud, Belgium.</p>
Media

NextPharma Technologies completes Euro 30m fundraising and acquires Bioserv Corporation

<p>UK-based contract services provider NextPharma Technologies has completed a Euro 30m fundraising round. </p>
Media

Cherwell to be renamed AnalytiChem UK

Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1 September 2025
Media

4basebio's new branding reflects both growth and the development of advanced genetic therapies

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market
Media

BioPharma Dynamics proudly sponsor GMCC Excellence Awards

BioPharma Dynamics is proud to continue their headline sponsorship of Greater Manchester Chamber of Commerce Excellence Awards, championing success and achievements of businesses within the Greater Manchester region
Media

Chemspec Europe 2024 conference programme unveiled

A detailed look at key speakers, sessions, and networking opportunities at the international exhibition
Media

Curia receives 2024 CDMO leadership award

Curia recognised for its service in the CDMO industry
Subscribe now